True Spring Salmon but as the share price heads south I'll be buying. It is hard to imagine how a company with so many recent achievements and long term achievemnets and working in leading edge science can be so undervalued.
With the share price so low it will be a long time before a NASDAQ listing is achieved.
Of course we may the orphan trial move ahead and more regional deals.
Regards
Toinv